Journal article

Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models

Abstract:: Background
Lung cancer is the second most common cancer in incidence and the leading cause of cancer deaths worldwide. Meanwhile, lung cancer screening with low-dose CT can reduce mortality. The UK National Screening Committee recommended targeted lung cancer screening on Sept 29, 2022, and asked for more modelling work to be done to help refine the recommendation. This study aims to develop and validate a risk prediction model—the CanPredict (lung) model—for lung canc... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Liao, W., Coupland, C. A. C., Burchardt, J., Baldwin, D. R., Gleeson, F. V., & Hippisley-Cox, J. (2023). Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models. Lancet Respiratory Medicine, 11(8), 685–697.

MLA Style

Liao, W., et al. “Predicting the Future Risk of Lung Cancer: Development, and Internal and External Validation of the CanPredict (Lung) Model in 19·67 Million People and Evaluation of Model Performance against Seven Other Risk Prediction Models.” Lancet Respiratory Medicine, vol. 11, no. 8, Elsevier, 2023, pp. 685–97.

Chicago Style

Liao, W, CAC Coupland, J Burchardt, DR Baldwin, FV Gleeson, and J Hippisley-Cox. 2023. “Predicting the Future Risk of Lung Cancer: Development, and Internal and External Validation of the CanPredict (Lung) Model in 19·67 Million People and Evaluation of Model Performance against Seven Other Risk Prediction Models.” Lancet Respiratory Medicine 11 (8): 685–97.
Share
Print

Access Document

Files:: Liao_et_al_2023_Predicting_the_future.pdf

(Preview, Version of record, pdf, 6.5MB, Terms of use)

Publisher copy:: 10.1016/S2213-2600(23)00050-4

Authors

+ Liao, W More by this author

Role:: Author

+ Coupland, CAC More by this author

Role:: Author

+ Burchardt, J More by this author

Role:: Author

+ Baldwin, DR More by this author

Role:: Author

+ Gleeson, FV More by this author

Role:: Author

More authors...

Contributors

+ DART initiative

Role:: Contributor

Publisher:: Elsevier
Journal:: Lancet Respiratory Medicine More from this journal
Volume:: 11
Issue:: 8
Pages:: 685-697
Publication date:: 2023-04-05
Acceptance date:: 2023-02-03
DOI:: 10.1016/S2213-2600(23)00050-4
EISSN:: 2213-2619
ISSN:: 2213-2600
Pmid:: 37030308

Language:: English
Keywords:: FFR
Pubs id:: 1337469
Local pid:: pubs:1337469
Deposit date:: 2023-05-16

Terms of use

Copyright holder:: Liao et al.
Copyright date:: 2023
Rights statement:: © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP